Fundraising Fox
/Companies
Sign in

​ OxCan (Oxford Cancer Analytics)

Oxford, GB · 8 known investors

Find your way into ​ OxCan (Oxford Cancer Analytics)

Each arrow is one introduction. Sign up to fill in the first one.

844 people can intro you to Andreas

Ask Hugo Fry to introduce you to Andreas Halner

You →Hugo · together at Zentiva →Andreas

194 people can intro you to Daniel

Ask Jamie Chen to introduce you to Daniel Szulc

You →Jamie · together at St. Michael's Hospital →Daniel

129 people can intro you to Heinrich

Ask Sam Okafor to introduce you to Heinrich Roder

You →Sam · together at Biodesix, Inc. →Heinrich

Sign up to find every way you can get introduced to ​ OxCan (Oxford Cancer Analytics)

  • Your email: who you already know at ​ OxCan (Oxford Cancer Analytics), and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ​ OxCan (Oxford Cancer Analytics) team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Oxford Cancer Analytics develops a diagnostics platform that combines reproducible proteomic measurement with AI to produce evidence-based insights supporting clinical decision-making. Its focus is on lung disease, beginning with Chronic Obstructive Pulmonary Disease (COPD) and extending to conditions such as lung cancer.

AI & Machine LearningBiotechMedical Devices

Founders & leadership

AHAndreas Halner
Andreas HalnerFounder and Head of Healthcare AIAndreas Halner held executive and board positions at pharmaceutical companies including GSK, Recordati, and Pharmakodex, and founded and led OnMedica, an e-health software company. He is now Founder and Head of Healthcare AI at Oxford Cancer Analytics, which develops an AI-driven proteomic diagnostics platform for lung disease.
HRHeinrich Roder
Heinrich RoderChief Technology OfficerHeinrich Roder is Chief Technology Officer of Oxford Cancer Analytics. He has over 20 years of experience leading research teams, with more than 50 peer-reviewed publications and 23 US patents to his name.
DS
Daniel SzulcChief Product OfficerDaniel Szulc is Chief Product Officer at Oxford Cancer Analytics, where he leads development of a diagnostics platform combining proteomic measurement with AI for clinical decision support. He has backgrounds in chemistry and biomedical engineering.

Investors · 8

Cross-Border Impact Ventures✓ confirmed by ​ OxCan (Oxford Cancer Analytics)Toronto · $2M – $10M

How we know: the company's own site · Not right? Tell us

Meridian Health Ventures✓ confirmed by ​ OxCan (Oxford Cancer Analytics)London

How we know: the company's own site · Not right? Tell us

UK Innovation & Science Seed Fund✓ confirmed by ​ OxCan (Oxford Cancer Analytics)Manchester · $127K – $635K

How we know: the company's own site · Not right? Tell us

Civilization Ventures Management, Llclisted by Civilization Ventures Management, LlcTiburon · $1M – $10M

How we know: Civilization Ventures Management, Llc's portfolio page · Not right? Tell us

DigitalDx Ventureslisted by DigitalDx VenturesMenlo Park

How we know: DigitalDx Ventures's portfolio page · Not right? Tell us

Onstagelisted by OnstageLondon
Oxford Technology Managementlisted by Oxford Technology ManagementHenley-on-Thames · $200K – $400K

How we know: Oxford Technology Management's portfolio page · Not right? Tell us

Frequently asked questions

What does ​ OxCan (Oxford Cancer Analytics) do?
Oxford Cancer Analytics develops a diagnostics platform that combines reproducible proteomic measurement with AI to produce evidence-based insights supporting clinical decision-making. Its focus is on lung disease, beginning with Chronic Obstructive Pulmonary Disease (COPD) and extending to conditions such as lung cancer.
Who founded ​ OxCan (Oxford Cancer Analytics)?
​ OxCan (Oxford Cancer Analytics) was founded by Andreas Halner.
Who are ​ OxCan (Oxford Cancer Analytics)'s investors?
​ OxCan (Oxford Cancer Analytics)'s investors include Eka Ventures, Cross-Border Impact Ventures, Meridian Health Ventures, UK Innovation & Science Seed Fund, Civilization Ventures Management, Llc, DigitalDx Ventures, Onstage, Oxford Technology Management.
Where is ​ OxCan (Oxford Cancer Analytics) headquartered?
​ OxCan (Oxford Cancer Analytics) is headquartered in Oxford, GB.